FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1985305469> ?p ?o ?g. }

• W1985305469 endingPage "797" @default.
• W1985305469 startingPage "789" @default.
• W1985305469 abstract "Objectives The purposes of this study were first, to evaluate the effectiveness of citalopram in treating behavioral disturbances in frontotemporal dementia (FTD) subjects and second, to determine whether an association exists between serotonergic function, as determined by a neuroendocrine challenge, and treatment response. Design Single-dose citalopram (30 mg per os) challenge followed by a 6-week open-label study. Setting Outpatients referred to memory clinics. Participants Fifteen patients suffering from FTD with severe behavioral and psychological symptoms of dementia. Intervention Following citalopram challenge, all patients were treated with citalopram titrated to a target dose of 40 mg once daily. Measurements Behavioral disturbances, using the Neuropsychiatric Inventory (NPI) (primary outcome) and Frontal Behavioural Inventory (secondary outcome), were assessed. Change in prolactin concentration following citalopram challenge was used as an index of central serotonergic response. Results Citalopram treatment was effective in treating behavioral symptoms, with significant decreases in NPI total score (F[2, 28] = 6.644, p = 0.004), disinhibition (F[2, 28] = 4.030, p = 0.029), irritability (F[2, 28] = 7.497, p = 0.003) and depression (F[2, 28] = 3.467, p = 0.045) scores over the 6 weeks. Significant improvement in Frontal Behavioural Inventory scores suggested that citalopram was also effective in the treatment ofbehaviors specific to FTD. A lower change score in concentration of prolactin was significantly positively correlated with greater improvement in the total NPI score from baseline to endpoint (r = 0.687, p = 0.005). A blunted response to a citalopram challenge, implying a dysfunctional serotonergic system, predicted a more positive treatment outcome. Conclusions The results suggest that despite the endogenous serotonin deficiency of FTD, citalopram treatment may be effective in targeting the behavioral disturbances characteristic of FTD. The purposes of this study were first, to evaluate the effectiveness of citalopram in treating behavioral disturbances in frontotemporal dementia (FTD) subjects and second, to determine whether an association exists between serotonergic function, as determined by a neuroendocrine challenge, and treatment response. Single-dose citalopram (30 mg per os) challenge followed by a 6-week open-label study. Outpatients referred to memory clinics. Fifteen patients suffering from FTD with severe behavioral and psychological symptoms of dementia. Following citalopram challenge, all patients were treated with citalopram titrated to a target dose of 40 mg once daily. Behavioral disturbances, using the Neuropsychiatric Inventory (NPI) (primary outcome) and Frontal Behavioural Inventory (secondary outcome), were assessed. Change in prolactin concentration following citalopram challenge was used as an index of central serotonergic response. Citalopram treatment was effective in treating behavioral symptoms, with significant decreases in NPI total score (F[2, 28] = 6.644, p = 0.004), disinhibition (F[2, 28] = 4.030, p = 0.029), irritability (F[2, 28] = 7.497, p = 0.003) and depression (F[2, 28] = 3.467, p = 0.045) scores over the 6 weeks. Significant improvement in Frontal Behavioural Inventory scores suggested that citalopram was also effective in the treatment ofbehaviors specific to FTD. A lower change score in concentration of prolactin was significantly positively correlated with greater improvement in the total NPI score from baseline to endpoint (r = 0.687, p = 0.005). A blunted response to a citalopram challenge, implying a dysfunctional serotonergic system, predicted a more positive treatment outcome. The results suggest that despite the endogenous serotonin deficiency of FTD, citalopram treatment may be effective in targeting the behavioral disturbances characteristic of FTD." @default.
• W1985305469 created "2016-06-24" @default.
• W1985305469 creator A5003058564 @default.
• W1985305469 creator A5036615199 @default.
• W1985305469 creator A5050914325 @default.
• W1985305469 creator A5056420149 @default.
• W1985305469 creator A5065186466 @default.
• W1985305469 creator A5076741931 @default.
• W1985305469 date "2012-09-01" @default.
• W1985305469 modified "2023-10-16" @default.
• W1985305469 title "Serotonergic Function and Treatment of Behavioral and Psychological Symptoms of Frontotemporal Dementia" @default.
• W1985305469 cites W1553552908 @default.
• W1985305469 cites W1847168837 @default.
• W1985305469 cites W188949016 @default.
• W1985305469 cites W1968385408 @default.
• W1985305469 cites W1973370830 @default.
• W1985305469 cites W1974583546 @default.
• W1985305469 cites W1975757759 @default.
• W1985305469 cites W1981577079 @default.
• W1985305469 cites W1991517279 @default.
• W1985305469 cites W1993386438 @default.
• W1985305469 cites W1998586446 @default.
• W1985305469 cites W2007951851 @default.
• W1985305469 cites W2012002443 @default.
• W1985305469 cites W2017438029 @default.
• W1985305469 cites W2017476377 @default.
• W1985305469 cites W2027823719 @default.
• W1985305469 cites W2028168767 @default.
• W1985305469 cites W2035444856 @default.
• W1985305469 cites W2037506962 @default.
• W1985305469 cites W2040025052 @default.
• W1985305469 cites W2045111237 @default.
• W1985305469 cites W2045793016 @default.
• W1985305469 cites W2047275853 @default.
• W1985305469 cites W2055338390 @default.
• W1985305469 cites W2057750895 @default.
• W1985305469 cites W2062024523 @default.
• W1985305469 cites W2062825859 @default.
• W1985305469 cites W2066554005 @default.
• W1985305469 cites W2074742396 @default.
• W1985305469 cites W2102343148 @default.
• W1985305469 cites W2111963393 @default.
• W1985305469 cites W2112549296 @default.
• W1985305469 cites W2113230922 @default.
• W1985305469 cites W2125729304 @default.
• W1985305469 cites W2148211031 @default.
• W1985305469 cites W2153448678 @default.
• W1985305469 cites W2184602814 @default.
• W1985305469 cites W4256146037 @default.
• W1985305469 doi "https://doi.org/10.1097/jgp.0b013e31823033f3" @default.
• W1985305469 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21878805" @default.
• W1985305469 hasPublicationYear "2012" @default.
• W1985305469 type Work @default.
• W1985305469 sameAs 1985305469 @default.
• W1985305469 citedByCount "92" @default.
• W1985305469 countsByYear W19853054692012 @default.
• W1985305469 countsByYear W19853054692013 @default.
• W1985305469 countsByYear W19853054692014 @default.
• W1985305469 countsByYear W19853054692015 @default.
• W1985305469 countsByYear W19853054692016 @default.
• W1985305469 countsByYear W19853054692017 @default.
• W1985305469 countsByYear W19853054692018 @default.
• W1985305469 countsByYear W19853054692019 @default.
• W1985305469 countsByYear W19853054692020 @default.
• W1985305469 countsByYear W19853054692021 @default.
• W1985305469 countsByYear W19853054692022 @default.
• W1985305469 countsByYear W19853054692023 @default.
• W1985305469 crossrefType "journal-article" @default.
• W1985305469 hasAuthorship W1985305469A5003058564 @default.
• W1985305469 hasAuthorship W1985305469A5036615199 @default.
• W1985305469 hasAuthorship W1985305469A5050914325 @default.
• W1985305469 hasAuthorship W1985305469A5056420149 @default.
• W1985305469 hasAuthorship W1985305469A5065186466 @default.
• W1985305469 hasAuthorship W1985305469A5076741931 @default.
• W1985305469 hasConcept C118552586 @default.
• W1985305469 hasConcept C126322002 @default.
• W1985305469 hasConcept C139719470 @default.
• W1985305469 hasConcept C15744967 @default.
• W1985305469 hasConcept C162324750 @default.
• W1985305469 hasConcept C170493617 @default.
• W1985305469 hasConcept C2775864247 @default.
• W1985305469 hasConcept C2776599063 @default.
• W1985305469 hasConcept C2776867660 @default.
• W1985305469 hasConcept C2777490545 @default.
• W1985305469 hasConcept C2780820931 @default.
• W1985305469 hasConcept C31487548 @default.
• W1985305469 hasConcept C37000724 @default.
• W1985305469 hasConcept C558461103 @default.
• W1985305469 hasConcept C71924100 @default.
• W1985305469 hasConceptScore W1985305469C118552586 @default.
• W1985305469 hasConceptScore W1985305469C126322002 @default.
• W1985305469 hasConceptScore W1985305469C139719470 @default.
• W1985305469 hasConceptScore W1985305469C15744967 @default.
• W1985305469 hasConceptScore W1985305469C162324750 @default.
• W1985305469 hasConceptScore W1985305469C170493617 @default.
• W1985305469 hasConceptScore W1985305469C2775864247 @default.
• W1985305469 hasConceptScore W1985305469C2776599063 @default.
• W1985305469 hasConceptScore W1985305469C2776867660 @default.

• next